# Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

> **NCT00004899** · PHASE2 · COMPLETED · sponsor: **Northwestern University**

## Conditions studied

- Leukemia
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Diseases

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** busulfan
- **DRUG:** etoposide
- **PROCEDURE:** autologous bone marrow transplantation

## Key facts

- **NCT ID:** NCT00004899
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2004-08
- **Final completion:** 2004-08
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004899, "Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00004899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*